Abstract
3,4-Methylenedioxymethamphetamine (MDMA), the main psychoactive component of the recreational drug ecstasy, is a potent serotonin (5-HT) releaser. In animals, MDMA induces 5-HT depletion and toxicity in 5-HT neurons. The aim of this study was to investigate both presynaptic (5-HT transporter, SERT) and postsynaptic (5-HT 2A receptor) markers of 5-HT transmission in recently abstinent chronic MDMA users compared with matched healthy controls. We hypothesized that MDMA use is associated with lower SERT density and concomitant upregulation of 5-HT 2A receptors. Positron emission tomography studies using the SERT ligand 11 CDASB and the 5-HT 2A receptor ligand 11 CMDL 100907 were evaluated in 13 current and recently detoxified MDMA users and 13 matched healthy controls. MDMA users reported a mean duration of ecstasy use of 8 years, regular exposure, and at least 2 weeks of abstinence before the scans. SERT and 5-HT 2A receptor availability (binding potential, BP ND) were analyzed with a two-tissue compartment model with arterial input function. Current recreational MDMA use was significantly associated with lower SERT BP ND and higher 5-HT 2A receptor BP ND in cortical, but not subcortical regions. Decreased SERT BP ND was regionally associated with upregulated 5-HT 2A receptor BP ND. In light of the animal literature, the most parsimonious interpretation is that repeated exposure to MDMA in humans, even in moderate amounts, leads to damage in 5-HT neuron terminals innervating the cortex. Alterations in mood, cognition, and impulse control associated with these changes might contribute to sustain MDMA use. The reversibility of these changes upon abstinence remains to be firmly established. © 2012 American College of Neuropsychopharmacology. All rights reserved.
Original language | English |
---|---|
Pages (from-to) | 1465-1473 |
Number of pages | 8 |
Journal | Neuropsychopharmacology |
Volume | 37 |
Issue number | 6 |
DOIs | |
Publication status | Published - May 2012 |
Keywords
- [11C]DASB
- [11C]MDL 100907
- cortical binding
- MDMA
- PET imaging
- serotonin markers